The challenge of treating complex autoimmune cytopenias in chronic lymphocytic leukemia

被引：4
|
作者：
Kaufman, Matthew [1 ]
Rai, Kanti [1 ]
机构：
[1] Long Isl Jewish Med Ctr, New Hyde Pk, NY 11040 USA
来源：
LEUKEMIA & LYMPHOMA | 2010年 / 51卷 / 04期
关键词：
D O I：
10.3109/10428191003754632
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：574 / 575
页数：2
相关论文
共 50 条
  • [31] Pre-Existing and Treatment-Emergent Autoimmune Cytopenias in Patients with Chronic Lymphocytic Leukemia Treated with Targeted Drugs
    Vitale, Candida
    Salvetti, Chiara
    Griggio, Valentina
    Scamuffa, Maria Cristina
    Zamprogna, Giulia
    Visentin, Andrea
    Cassin, Ramona
    Laurenti, Luca
    Murru, Roberta
    Rivela, Paolo
    Marchetti, Monia
    Gentile, Massimo
    Pennese, Elsa
    Reda, Gianluigi
    Trentin, Livio
    Tedeschi, Alessandra
    Mauro, Francesca Romana
    Foa, Robin
    Boccadoro, Mario
    Coscia, Marta
    BLOOD, 2019, 134
  • [32] Regulatory T-cells in B-cell chronic lymphocytic leukemia: their role in disease progression and autoimmune cytopenias
    Lad, Deepesh P.
    Varma, Subhash
    Varma, Neelam
    Sachdeva, Man Updesh Singh
    Bose, Parveen
    Malhotra, Pankaj
    LEUKEMIA & LYMPHOMA, 2013, 54 (05) : 1012 - 1019
  • [33] RETRACTED: Rituximab-cyclophosphamide-dexamethasone combination in management of autoimmune cytopenias associated with chronic lymphocytic leukemia (Retracted Article)
    Michallet, Anne-Sophie
    Rossignol, Julien
    Cazin, Bruno
    Ysebaert, Loic
    LEUKEMIA & LYMPHOMA, 2011, 52 (07) : 1401 - 1403
  • [34] Ibrutinib in combination with rituximab is highly effective in treatment of chronic lymphocytic leukemia patients with steroid refractory and relapsed autoimmune cytopenias
    Eugene Nikitin
    Maria Kislova
    Dmitry Morozov
    Vera Belyakova
    Anna Suvorova
    Julia Sveshnikova
    Galina Vyscub
    Irina Matveeva
    Maria Shirokova
    Anna Shipaeva
    Tatyana Klitochenko
    Polina Makarovskaya
    Elena Dmitrieva
    Bella Biderman
    Andrei Sudarikov
    Tatyana Obukhova
    Olga Samoilova
    Kamil Kaplanov
    Tatyana Konstantinova
    Olga Mayorova
    Irina Poddubnaya
    Vadim Ptushkin
    Leukemia, 2023, 37 : 1464 - 1473
  • [35] Treating chronic lymphocytic leukemia with thalidomide and lenalidomide
    Giannopoulos, Krzysztof
    Mertens, Daniel
    Stilgenbauer, Stephan
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (18) : 2857 - 2864
  • [36] Diagnosing and Treating Chronic Lymphocytic Leukemia in 2009
    Kaufman, Matthew
    Rubin, Jason
    Rai, Kanti
    ONCOLOGY-NEW YORK, 2009, 23 (12): : 1030 - 1037
  • [37] INTENSIVE LEUKAPHERESIS IN THE MANAGEMENT OF CYTOPENIAS IN PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) AND LYMPHOCYTIC LYMPHOMA
    COOPER, IA
    DING, JC
    ADAMS, PB
    QUINN, MA
    BRETTELL, M
    AMERICAN JOURNAL OF HEMATOLOGY, 1979, 6 (04) : 387 - 398
  • [38] Refractory Chronic Lymphocytic Leukemia: A Therapeutic Challenge
    Smolej, Lukas
    CURRENT CANCER DRUG TARGETS, 2016, 16 (08) : 701 - 709
  • [39] Chronic Lymphocytic Leukemia with Dermatomyositis: A Therapeutic Challenge
    Kumar, Sudhir
    Gogia, Ajay
    Gupta, Ritu
    Mallick, Soumya
    TURKISH JOURNAL OF HEMATOLOGY, 2020, 37 (04) : 291 - 292
  • [40] A matter of debate in chronic lymphocytic leukemia: is the occurrence of autoimmune disorders an indicator of chronic lymphocytic leukemia therapy?
    Strati, Paolo
    Caligaris-Cappio, Federico
    CURRENT OPINION IN ONCOLOGY, 2011, 23 (05) : 455 - 460
12345